In vivo profiling of metastatic double knockouts through CRISPR–Cpf1 screens
- 8 April 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Methods
- Vol. 16 (5), 405-408
- https://doi.org/10.1038/s41592-019-0371-5
Abstract
Systematic investigation of the genetic interactions that influence metastatic potential has been challenging. Here we developed massively parallel CRISPR–Cpf1/Cas12a crRNA array profiling (MCAP), an approach for combinatorial interrogation of double knockouts in vivo. We designed an MCAP library of 11,934 arrays targeting 325 pairwise combinations of genes implicated in metastasis. By assessing the metastatic potential of the double knockouts in mice, we unveiled a quantitative landscape of genetic interactions that drive metastasis.Keywords
This publication has 27 references indexed in Scilit:
- Integrative clinical genomics of metastatic cancerNature, 2017
- Emerging Biological Principles of MetastasisCell, 2017
- Multiplex gene editing by CRISPR–Cpf1 using a single crRNA arrayNature Biotechnology, 2016
- Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEMProceedings of the National Academy of Sciences of the United States of America, 2016
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas SystemCell, 2015
- Massively parallel high-order combinatorial genetics in human cellsNature Biotechnology, 2015
- Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and MetastasisCell, 2015
- First indication for a functional CRISPR/Cas system in Francisella tularensisInternational Journal of Medical Microbiology, 2013
- Quantitative genetic-interaction mapping in mammalian cellsNature Methods, 2013
- Dicer1 functions as a haploinsufficient tumor suppressorGenes & Development, 2009